2007 - a special anniversary year for Dräger

Drägerwerk AG100 years ago in October 1907, company founder, Johann Heinrich Dräger, was awarded a patent for the Pulmotor, the first mobile short-term respirator. This marked the birth of ventilation technology development at Dräger. Simple, reliable, and extremely effective, the apparatus - transported in a wooden casket - quickly became a standard piece of equipment used by rescue services throughout Germany.

It all began early in the 20th century, when, on a trip to England, Johann Heinrich Dräger witnessed a young man being pulled out the Thames and resuscitated using the traditional Schaeffer method. Still in London, Dräger then produced some initial sketches. Upon returning to Lübeck, he began developing a technical solution for a resuscitation machine. After a few more modifications, the result was "Dräger's Pulmotor, the first automatic oxygen resuscitation machine for artificial respiration", manufactured in the factory and construction institute for oxygen apparatus known at the time as Drägerwerk in Lübeck, Germany. In his memoirs, Johann Heinrich Dräger spoke of the Pulmotor as having enabled well over 1,000 officially attested resuscitations by March 1, 1917.

Successful attempts at resuscitating miners poisoned by carbon monoxide, for example, paid testament to the success of the oxygen machine just a short time after its market launch in 1908 - in defiance of the skeptics of positive pressure respiration. Dräger consequently started serial production which, even at that time, proved extremely successful in the United States. The first Dräger company on US soil was founded in the US in 1907, too: at 11 Broadway in New York City; shortly afterwards, the company was moved to Pittsburgh, PA, and renamed Draeger Oxygen Apparatus Company. Internationality and innovativeness have a long tradition at Dräger.

In the US, the Pulmotor respirator was bought mainly to equip rescue teams of mining companies (mine rescuers) and fire departments, hence Dräger's legendary reputation for breathing apparatus in the US: mine rescuers equipped with Dräger apparatus were known as Draegermen.

The Oxylog product family, which is still going strong today, superseded the successful Pulmotor in 1978. After the first applications of the Iron Lung in the fifties, long-term positive pressure ventilation was introduced. Today, this is fulfilled by the intensive care ventilators of the Evita family. All of these devices are based on the technical specifications of the Pulmotor. In fact, advancements in this technical innovation from the beginning of the 20th century are now not only used for emergency and long-term ventilation, but also in anesthesia and for home care.

For further information, please visit:
http://www.draeger.com

Most Popular Now

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Digital ECGs at Barts Health: A High-Imp…

Opinion Article by Dr Krishnaraj Sinhji Rathod, consultant in interventional cardiology, Barts Health NHS Trust. Picture the moment. A patient in an ambulance, enroute to hospital with new chest pain. Paramedics...

Study Sheds Light on Hurdles Faced in Tr…

Implementing artificial intelligence (AI) into NHS hospitals is far harder than initially anticipated, with complications around governance, contracts, data collection, harmonisation with old IT systems, finding the right AI tools...

Using Deep Learning for Precision Cancer…

Altuna Akalin and his team at the Max Delbrück Center have developed a new tool to more precisely guide cancer treatment. Described in a paper published in Nature Communications, the...

New AI Approach Paves Way for Smarter T-…

Researchers have harnessed the power of artificial intelligence (AI) to tackle one of the most complex challenges in immunology: predicting how T cells recognize and respond to specific peptide antigens...

Study Used AI Models to Improve Predicti…

Chronic kidney disease (CKD) is a complex condition marked by a gradual decline in kidney function, which can ultimately progress to end-stage renal disease (ESRD). Globally, the prevalence of the...

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...